Blue Jet Healthcare IPO gets green signal from Sebi. Details here
- Blue Jet received its final observation letter on January 9 from Sebi. Kotak Mahindra Capital Company is the co-ordinating lead manager for the issue.
- As per the draft prospectus, the IPO is purely an offer for sale (OFS) where selling shareholders will offload up to 21,683,178 equity shares.
Blue Jet Healthcare has received market regulator Sebi's approval to raise funds from an initial public offering (IPO). Blue Jet's issue is entirely offer for sale (OFS), hence, the company will not receive any proceeds. The company filed for an IPO in September last year. Blue Jet offers niche products targeted toward innovator pharmaceutical companies and multinational generic pharmaceutical firms.
Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!Let’s get started
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more